MINERAL OIL AND WHITE PETROLATUM

MINERAL OIL AND WHITE PETROLATUM was reported 518 times

MINERAL OIL AND WHITE PETROLATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFLAMMATION OF LACRIMAL PASSAGE 1 0.0200
1 PELVIC OPERATION 1 0.0152
2 WRONG PRODUCT PROCURED 1 0.0152
3 ASTHENOPIA 80 0.0145
4 FOREIGN BODY SENSATION IN EYES 80 0.0125
5 CORNEAL CYST 1 0.0103
6 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
7 KERATOCONUS 2 0.0053
8 EYE DISCHARGE 54 0.0052
9 PRODUCT INTOLERANCE 1 0.0045
10 RHEUMATOID VASCULITIS 1 0.0044
11 INJURY CORNEAL 2 0.0038
12 INSTILLATION SITE DISCHARGE 1 0.0038
13 REACTION TO PRESERVATIVES 3 0.0037
14 SUPERFICIAL INJURY OF EYE 4 0.0037
15 CHEMICAL BURNS OF EYE 1 0.0036
16 OPEN ANGLE GLAUCOMA 2 0.0033
17 EYE IRRITATION 175 0.0030
18 GLASSY EYES 2 0.0028
19 OCULAR HYPERAEMIA 129 0.0027
20 INSTILLATION SITE PRURITUS 1 0.0027
21 PRODUCT DROPPER ISSUE 2 0.0025
22 EYE PRURITUS 83 0.0025
23 LAGOPHTHALMOS 1 0.0024
24 DRY EYE 122 0.0024
25 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
26 EYELID IRRITATION 5 0.0020
27 BLEPHARAL PIGMENTATION 1 0.0020
28 EYE ALLERGY 3 0.0019
29 LACRIMATION INCREASED 58 0.0019
30 INSTILLATION SITE ERYTHEMA 1 0.0019
31 ABNORMAL SENSATION IN EYE 8 0.0019
32 EYE PAIN 104 0.0018
33 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
34 CHEMICAL BURN 2 0.0017
35 LUMBAR RADICULOPATHY 2 0.0017
36 MEDICATION RESIDUE PRESENT 8 0.0017
37 CHALAZION 1 0.0016
38 MACULAR FIBROSIS 1 0.0015
39 SCLERAL HYPERAEMIA 1 0.0015
40 CYTOKINE STORM 1 0.0015
41 CORNEAL ABRASION 2 0.0015
42 PRODUCT PHYSICAL CONSISTENCY ISSUE 8 0.0014
43 EYELID MARGIN CRUSTING 4 0.0014
44 EXCESSIVE EYE BLINKING 2 0.0014
45 OCULAR DISCOMFORT 15 0.0013
46 CORNEAL TRANSPLANT 1 0.0013
47 RETINAL TEAR 3 0.0012
48 ENDOCRINE OPHTHALMOPATHY 1 0.0012
49 EYELIDS PRURITUS 3 0.0010
50 INNER EAR DISORDER 1 0.0009
51 INSTILLATION SITE REACTION 1 0.0009
52 VISION BLURRED 126 0.0009
53 CORNEAL DISORDER 2 0.0009
54 INSTILLATION SITE IRRITATION 1 0.0008
55 INSTILLATION SITE PAIN 2 0.0008
56 OBLITERATIVE BRONCHIOLITIS 1 0.0008
57 THERAPEUTIC PROCEDURE 1 0.0007
58 CONNECTIVE TISSUE DISORDER 1 0.0007
59 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
60 DARK CIRCLES UNDER EYES 1 0.0007
61 NIGHT BLINDNESS 1 0.0006
62 SEBORRHOEIC DERMATITIS 1 0.0006
63 EYELID OEDEMA 7 0.0006
64 PRODUCT COUNTERFEIT 1 0.0006
65 ERYTHEMA OF EYELID 3 0.0006
66 METAMORPHOPSIA 1 0.0005
67 DENTAL CARE 1 0.0005
68 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
69 MULTI-ORGAN DISORDER 1 0.0005
70 SWELLING OF EYELID 3 0.0005
71 EYE SWELLING 17 0.0005
72 EYELID DISORDER 1 0.0004
73 BLINDNESS TRANSIENT 3 0.0004
74 CHEMICAL BURN OF SKIN 1 0.0004
75 ENDODONTIC PROCEDURE 1 0.0004
76 SUBDURAL HAEMORRHAGE 1 0.0004
77 ULCERATIVE KERATITIS 1 0.0004
78 PERIORBITAL SWELLING 2 0.0004
79 PRODUCT CONTAINER ISSUE 3 0.0003
80 ADENOVIRUS INFECTION 1 0.0003
81 PRODUCT PACKAGING ISSUE 3 0.0003
82 EYE INFLAMMATION 3 0.0003
83 SKIN EROSION 1 0.0003
84 FACIAL PARESIS 1 0.0003
85 PRODUCT CONTAMINATION 1 0.0003
86 SCLERODERMA 1 0.0003
87 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
88 EPIGASTRIC DISCOMFORT 1 0.0003
89 BLEPHARITIS 1 0.0002
90 CARDIAC FAILURE CHRONIC 1 0.0002
91 PRODUCT DISPENSING ISSUE 1 0.0002
92 HORDEOLUM 1 0.0002
93 RHINITIS ALLERGIC 1 0.0002
94 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
95 PRODUCT QUALITY ISSUE 28 0.0002
96 EXPIRED DRUG ADMINISTERED 1 0.0002
97 PRODUCT COLOUR ISSUE 1 0.0002
98 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
99 DECREASED ACTIVITY 2 0.0002
100 EYE DISORDER 6 0.0002
101 GASTRIC ULCER HAEMORRHAGE 1 0.0002
102 MACULAR OEDEMA 1 0.0002
103 MADAROSIS 2 0.0002
104 PRODUCT LABEL CONFUSION 1 0.0002
105 CATARACT OPERATION 1 0.0002
106 MACULAR DEGENERATION 2 0.0002
107 FIBROMYALGIA 4 0.0002
108 SCOLIOSIS 1 0.0002
109 PHOTOPHOBIA 3 0.0002
110 INFUSION SITE SWELLING 1 0.0002
111 PRODUCT PREPARATION ISSUE 1 0.0002
112 BRONCHIECTASIS 1 0.0001
113 POSTOPERATIVE WOUND INFECTION 1 0.0001
114 WRONG PRODUCT ADMINISTERED 1 0.0001
115 PRODUCT LABEL ISSUE 1 0.0001
116 EYE MOVEMENT DISORDER 1 0.0001
117 ONYCHOCLASIS 1 0.0001
118 HAND FRACTURE 1 0.0001
119 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
120 HYPOALBUMINAEMIA 1 0.0001
121 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
122 VITAMIN D DECREASED 1 0.0001
123 PSEUDOMONAS INFECTION 1 0.0001
124 NAIL DISORDER 1 0.0001
125 FACIAL PAIN 1 0.0001
126 GLAUCOMA 2 0.0001
127 LIGAMENT SPRAIN 1 0.0001
128 CATARACT 6 0.0001
129 INABILITY TO AFFORD MEDICATION 1 0.0001
130 DRY THROAT 1 0.0001
131 INITIAL INSOMNIA 1 0.0001
132 SKIN LACERATION 1 0.0001
133 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
134 FOOT DEFORMITY 1 0.0001
135 VISUAL IMPAIRMENT 11 0.0001
136 EYE INFECTION 1 0.0001
137 CYTOPENIA 1 0.0001
138 INTRAOCULAR PRESSURE INCREASED 1 0.0001
139 MYDRIASIS 1 0.0001
140 ROTATOR CUFF SYNDROME 1 0.0001
141 GASTRITIS 2 0.0001
142 EYE HAEMORRHAGE 1 0.0001
143 IMMUNODEFICIENCY 1 0.0001
144 DEVICE RELATED INFECTION 1 0.0001
145 THYROID DISORDER 1 0.0001
146 LUNG INFECTION 1 0.0001
147 PRODUCT USE COMPLAINT 1 0.0001
148 DRUG INEFFECTIVE 83 0.0001
149 HIP FRACTURE 2 0.0001
150 BACK DISORDER 1 0.0001
151 EXPIRED PRODUCT ADMINISTERED 2 0.0001
152 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
153 ORTHOSTATIC HYPOTENSION 1 0.0001
154 HEAD DISCOMFORT 1 0.0001
155 RASH PRURITIC 3 0.0001
156 RESTLESS LEGS SYNDROME 1 0.0001
157 CONJUNCTIVITIS 1 0.0001
158 HYPOCALCAEMIA 1 0.0001
159 FRACTURE 1 0.0001
160 GASTRIC ULCER 1 0.0001
161 HERNIA 1 0.0001
162 HAEMORRHOIDS 1 0.0001
163 NASAL CONGESTION 3 0.0001
164 DISABILITY 1 0.0001
165 SINUS DISORDER 1 0.0001
166 UPPER LIMB FRACTURE 1 0.0001
167 CYTOKINE RELEASE SYNDROME 1 0.0000
168 MOUTH ULCERATION 1 0.0000
169 OSTEOARTHRITIS 2 0.0000
170 POOR QUALITY SLEEP 1 0.0000
171 BALANCE DISORDER 4 0.0000
172 PRODUCT DOSE OMISSION 3 0.0000
173 PRODUCT DISPENSING ERROR 1 0.0000
174 TRANSAMINASES INCREASED 1 0.0000
175 ORAL PAIN 1 0.0000
176 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
177 PRODUCT AVAILABILITY ISSUE 1 0.0000
178 SKIN IRRITATION 2 0.0000
179 NEURALGIA 1 0.0000
180 OSTEONECROSIS OF JAW 1 0.0000
181 PNEUMONIA ASPIRATION 1 0.0000
182 JOINT STIFFNESS 1 0.0000
183 HAEMOPTYSIS 1 0.0000
184 NECK PAIN 2 0.0000
185 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
186 HYPERSOMNIA 1 0.0000
187 HERPES ZOSTER 2 0.0000
188 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
189 APHASIA 1 0.0000
190 HYPERSENSITIVITY 6 0.0000
191 CYSTITIS 1 0.0000
192 RHINORRHOEA 2 0.0000
193 SWELLING FACE 2 0.0000
194 VISUAL ACUITY REDUCED 1 0.0000
195 VIRAL INFECTION 1 0.0000
196 NIGHTMARE 1 0.0000
197 RASH MACULAR 1 0.0000
198 COVID-19 5 0.0000
199 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
200 DRUG EFFECT INCOMPLETE 1 0.0000
201 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
202 EPISTAXIS 2 0.0000
203 PERIPHERAL SWELLING 4 0.0000
204 ARTHRITIS 2 0.0000
205 DRY MOUTH 2 0.0000
206 BLINDNESS 1 0.0000
207 ROAD TRAFFIC ACCIDENT 1 0.0000
208 WITHDRAWAL SYNDROME 1 0.0000
209 HYPERHIDROSIS 3 0.0000
210 HYPOACUSIS 1 0.0000
211 MUSCULOSKELETAL STIFFNESS 2 0.0000
212 DRY SKIN 3 0.0000
213 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
214 TINNITUS 1 0.0000
215 ABDOMINAL PAIN 5 0.0000
216 MIGRAINE 2 0.0000
217 BLOOD PRESSURE INCREASED 3 0.0000
218 SINUSITIS 2 0.0000
219 THERAPY CESSATION 1 0.0000
220 ILLNESS 2 0.0000
221 INFLAMMATION 1 0.0000
222 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
223 DERMATITIS ATOPIC 1 0.0000
224 PANCREATITIS 1 0.0000
225 CONSTIPATION 4 0.0000
226 FALL 6 0.0000
227 DYSPHONIA 1 0.0000
228 SURGERY 1 0.0000
229 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
230 DISCOMFORT 1 0.0000
231 FEELING HOT 1 0.0000
232 PNEUMONIA 5 0.0000
233 FEBRILE NEUTROPENIA 1 0.0000
234 DEHYDRATION 2 0.0000
235 ERYTHEMA 3 0.0000
236 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
237 INJECTION SITE REACTION 1 0.0000
238 THERAPY INTERRUPTED 1 0.0000
239 DYSGEUSIA 1 0.0000
240 CONDITION AGGRAVATED 4 0.0000
241 INCORRECT DOSE ADMINISTERED 3 0.0000
242 PRURITUS 5 0.0000
243 BACK PAIN 3 0.0000
244 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
245 SKIN EXFOLIATION 1 0.0000
246 PRODUCT STORAGE ERROR 1 0.0000
247 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
248 HEADACHE 7 0.0000
249 GASTROINTESTINAL DISORDER 1 0.0000
250 ADVERSE DRUG REACTION 1 0.0000
251 NASOPHARYNGITIS 2 0.0000
252 OROPHARYNGEAL PAIN 1 0.0000
253 BREAST CANCER 1 0.0000
254 CARDIAC DISORDER 1 0.0000
255 GAIT DISTURBANCE 2 0.0000
256 CONTUSION 1 0.0000
257 HEART RATE INCREASED 1 0.0000
258 SYNCOPE 1 0.0000
259 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
260 HAEMOGLOBIN DECREASED 1 0.0000
261 ABDOMINAL PAIN UPPER 2 0.0000
262 ARTHRALGIA 4 0.0000
263 INFLUENZA 1 0.0000
264 JOINT SWELLING 1 0.0000
265 EMOTIONAL DISTRESS 1 0.0000
266 OEDEMA PERIPHERAL 1 0.0000
267 PAIN 5 0.0000
268 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
269 DIZZINESS 4 0.0000
270 OFF LABEL USE 7 0.0000
271 INSOMNIA 2 0.0000
272 MEMORY IMPAIRMENT 1 0.0000
273 INFECTION 1 0.0000
274 MALAISE 3 0.0000
275 PRODUCT DOSE OMISSION ISSUE 2 0.0000
276 INJECTION SITE PAIN 2 0.0000
277 PARAESTHESIA 1 0.0000
278 DIARRHOEA 4 0.0000
279 TREMOR 1 0.0000
280 URTICARIA 1 0.0000
281 MYALGIA 1 0.0000
282 PYREXIA 2 0.0000
283 MUSCLE SPASMS 1 0.0000
284 PRODUCT USE ISSUE 1 0.0000
285 RASH 2 0.0000
286 FEELING ABNORMAL 1 0.0000
287 NAUSEA 3 0.0000
288 COUGH 1 0.0000
289 DYSPNOEA 2 0.0000
290 ANXIETY 1 0.0000
291 ASTHENIA 1 0.0000
292 FATIGUE 2 0.0000
293 DEATH 2 0.0000
294 VOMITING 1 0.0000